Literature DB >> 12481254

Inhibition of the enzymatic activity of prostate-specific antigen by boric acid and 3-nitrophenyl boronic acid.

Maria T Gallardo-Williams1, Robert R Maronpot, Robert N Wine, Susan H Brunssen, Robert E Chapin.   

Abstract

BACKGROUND: Prostate specific antigen (PSA) is a well-established marker of prostate cancer, but it can also degrade extracellular matrix proteins such as fibronectin and could be involved in tumor progression and metastasis. In this study, we have addressed the use of boric acid and 3-nitrophenyl boronic acid (NPBA) as PSA inhibitors in vitro.
METHODS: The inhibition of PSA by boric acid was studied by using specific fluorogenic substrates. Fibronectin, a biologically relevant substrate for PSA, was used as a substrate in a zymographic assay, and the degradation of fibronectin by PSA in the presence of boric acid and NPBA was followed by Western Blot.
RESULTS: Low concentrations of boric acid partially inhibited the proteolytic activity of PSA toward a synthetic fluorogenic substrate. Also, by Western blot, we have found significant inhibition in the proteolysis of fibronectin by PSA in the presence of boric acid as well as NPBA. Results indicate that the boronated compounds used in this study can be used for the modulation of PSA activity.
CONCLUSION: PSA activity is inhibited in vitro by boric acid and NPBA. If degradation of fibronectin by PSA were, in fact, an important step in the progression of prostate cancer, then borate-induced inhibition of PSA activity should help reduce the development and proliferation of prostate carcinomas. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12481254     DOI: 10.1002/pros.10166

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  11 in total

1.  Disodium pentaborate decahydrate (DPD) induced apoptosis by decreasing hTERT enzyme activity and disrupting F-actin organization of prostate cancer cells.

Authors:  Mehmet Korkmaz; Cigir Biray Avcı; Cumhur Gunduz; Duygu Aygunes; Burcu Erbaykent-Tepedelen
Journal:  Tumour Biol       Date:  2014-02

2.  Cytotoxic and apoptotic effects of boron compounds on leukemia cell line.

Authors:  Zerrin Canturk; Yağmur Tunali; Seval Korkmaz; Zafer Gulbaş
Journal:  Cytotechnology       Date:  2014-08-27       Impact factor: 2.058

3.  Human seminal proteinase and prostate-specific antigen are the same protein.

Authors:  Abdul Waheed; Md Imtaiyaz Hassan; Robert L Van Etten; Faizan Ahmad
Journal:  J Biosci       Date:  2008-06       Impact factor: 1.826

4.  Phenylboronic acid selectively inhibits human prostate and breast cancer cell migration and decreases viability.

Authors:  Tiffany M Bradke; Casey Hall; Stephen W Carper; George E Plopper
Journal:  Cell Adh Migr       Date:  2008-07-23       Impact factor: 3.405

5.  Thiophilic-interaction chromatography of enzymatically active tissue prostate-specific antigen (T-PSA) and its modulation by zinc ions.

Authors:  A K Satheesh Babu; M A Vijayalakshmi; Gary J Smith; Kailash C Chadha
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-04       Impact factor: 3.205

6.  Protective Effect of Boric Acid on Oxidative DNA Damage In Chinese Hamster Lung Fibroblast V79 Cell Lines.

Authors:  Sezen Yılmaz; Aylin Ustundag; Ozge Cemiloglu Ulker; Yalcın Duydu
Journal:  Cell J       Date:  2016-01-17       Impact factor: 2.479

7.  Hollow boron nitride nanospheres as boron reservoir for prostate cancer treatment.

Authors:  Xia Li; Xiupeng Wang; Jun Zhang; Nobutaka Hanagata; Xuebin Wang; Qunhong Weng; Atsuo Ito; Yoshio Bando; Dmitri Golberg
Journal:  Nat Commun       Date:  2017-01-06       Impact factor: 14.919

8.  Borax Pentahydrate and Disodium Pentaborate Decahydrate Are Candidates as Anti-leukemic Drug Components by Inducing Apoptosis and Changing Bax/Bcl-2 Ratio in HL-60 Cell Line.

Authors:  Tuğba Erkmen; Belgin Sert Serdar; Halil Ateş; Mehmet Korkmaz; Semra Koçtürk
Journal:  Biol Trace Elem Res       Date:  2021-06-29       Impact factor: 3.738

Review 9.  Nothing Boring About Boron.

Authors:  Lara Pizzorno
Journal:  Integr Med (Encinitas)       Date:  2015-08

10.  Cellular changes in boric acid-treated DU-145 prostate cancer cells.

Authors:  W T Barranco; C D Eckhert
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.